Lupin receives USFDA EIR for Vizag API Facility Ruchika Sharma14 May 2020 4:19 PM ISTMumbai: Lupin Limited has announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration...
Ind-Swift Labs gets USFDA EIR for Derabassi API facility Ruchika Sharma12 May 2020 1:23 PM ISTMumbai: Ind-Swift Laboratories Limited has received the Establishment Inspection Report (EIR) from the USFDA, for the Surveillance GMP inspection of...
Cipla gets USFDA EIR for Bommasandra API facility Ruchika Sharma10 May 2020 10:00 AM ISTBangalore: Cipla has announced that it has received Establishment Inspection Report (EIR) from USFDA for its API manufacturing facility in...
Biocon gets EIR for Small Molecules API Manufacturing Facility for Pre -Approval, GMP USFDA Inspection Ruchika Sharma8 May 2020 2:29 PM ISTBengaluru: Biocon has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the Pre-Approval and GMP...
Pharma Expansion: Bajaj Healthcare to buy stressed assets from Saraswat Cooperative Bank for Rs 61 crore Ruchika Sharma30 April 2020 1:20 PM ISTThe targeted assets have installed capacity of 111 metric tonnes per month and are capable of manufacturing bulk drugs and active pharmaceutical...
Reducing Dependency on China Imports: IICT, LAXAI LifeSciences tie-up for key pharma intermediate Ruchika Sharma25 April 2020 2:10 PM ISTThe collaboration will primarily focus on Umifenovir, Remdesivir, and a key intermediate of Hydroxychloroquine (HCQ)
Grant Infrastructure Status to Bulk Drug Industry : CII Report on API sector Meghna A Singhania19 April 2020 11:15 AM ISTNew Delhi: While Indian pharmaceutical industry has rightfully gained the epithet 'pharmacy to the world', it has also become highly import dependant...
Cabinet Apprised on the progress made under NHM Medical Dialogues Bureau7 Jan 2019 10:00 AM ISTIn respect of Malaria, the Annual Parasite Incidence (API) declined to 0.84 in 2016 from 1.10 in 2011. In 2017 malaria incidence went down by 30% and...
Cadila clarifies US regulatory warning on Gujarat units savita thakur thakur1 Jan 2016 12:13 PM ISTAhmedabad, Pharma major Cadila Healthcare clarified that products from its Moraiya and Ahmedabad plants in Gujarat were safe in the market and...
Sharon Bio-medicine foresees growth post drug supply to US Pooja Bhatia Bhatia16 Dec 2015 1:53 PM ISTIn an exclusive conversation with cnbctv18, CFO of Sharon Bio-medicine Mohan P. Kala has discussed about the company's anticipation of growth after...
Unichem Laboratories receives USFDA approval for hypertension drug Pooja Bhatia Bhatia9 Dec 2015 10:40 AM ISTUnichem Laboratories has received the approval from USFDA for Irbesartan tablets USP indicated to treat hypertension. The product will be...
Natco Pharma suspends work at Chennai plant due to flood savita thakur thakur4 Dec 2015 12:32 PM ISTNew Delhi: Drug firm Natco Pharma today said its active pharmaceuticals ingredient plant at Chennai has suspended operations due to flooding caused by...
